Gelteq LtdGELS

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$0.55
Market cap
$5.9M
P/E
—
Revenue (FY)
$165,645
Net income
-$6.6M
Dividend yield
—
1-year total return
-59.3%
Net margin
-4011.9%
Revenue growth
—
Debt / equity
0.00x

What Gelteq Ltd does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year2022202320242025
Revenue—$79,843—$165,645
Net income—-$3.5M-$3.5M-$6.6M
Free cash flow—-$1.8M-$1.1M-$5.5M

More on GELS.

Figures from Gelteq Ltd's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.